ng after can't be solved by gene therapy. Beyond that, and Editas's ongoing immuno-oncology work with Juno, Editas has done some very early work in Duchenne muscular dystrophy and is exploring ways to repair a mutant hemoglobin gene— something that could have an impact in a range of bleeding disorders. Th

Precision Medicine, with reference to Super Genes? Would Rudi Tanzi be interested in joining as a co-author? Perhaps he has additional insights on Duchenne's as a neuromuscular disorder? We have not heard back from Paul & Bess, so do not know their level of interest, or if they wish to be listed as co-